Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY21 results · Apr–Jun 2020
Metropolis Healthcare reported revenue from operations of ₹143.13 crore (down 29.6% from Q1 FY20) and net profit of ₹2.88 crore (down 89.3% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 143.13 | 203.30 | −29.6% | 206.97 | −30.8% |
| Other income | 3.15 | 1.55 | +103.9% | 3.07 | +2.7% |
| Total income | 146.28 | 204.84 | −28.6% | 210.05 | −30.4% |
| Profit before tax | 3.51 | 39.67 | −91.1% | 23.39 | −85.0% |
| Net profit for the period | 2.88 | 26.91 | −89.3% | 15.49 | −81.4% |
| Attributable to shareholders of the company | 2.90 | 26.78 | −89.2% | 15.49 | −81.3% |
| EPS, basic (₹) | 0.57 | 5.34 | −89.3% | 3.09 | −81.6% |
| Net margin (%) | 2.0 | 13.2 | 7.5 |
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 110.78 | 156.96 | −29.4% | 163.16 | −32.1% |
| Other income | 2.37 | 0.83 | +187.0% | 25.72 | −90.8% |
| Total income | 113.15 | 157.79 | −28.3% | 188.88 | −40.1% |
| Profit before tax | 2.07 | 26.97 | −92.3% | 34.94 | −94.1% |
| Net profit for the period | 2.19 | 18.32 | −88.0% | 29.76 | −92.6% |
| EPS, basic (₹) | 0.43 | 3.65 | −88.2% | 5.93 | −92.7% |
| Net margin (%) | 2.0 | 11.7 | 18.2 |
Consolidated
- Filed with BSE
- 12 Aug 2020, 14:32 IST
- Board meeting
- 11 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Aug 2020, 14:32 IST
- Board meeting
- 11 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE